Will Alphabet 'Storm Back?' Plus: Progressive, D.R. Horton And Pfizer On CNBC's 'Final Trades'
Portfolio Pulse from Avi Kapoor
On CNBC's 'Halftime Report Final Trades,' experts highlighted their picks: Pfizer (PFE) for its promising Phase 3 study results, Alphabet (GOOG/GOOGL) despite a recent setback with its Pixel 8 smartphone, Progressive (PGR) for its solid earnings and growth prospects, and D.R. Horton (DHI) for its attractive valuation. Notably, Alphabet's Google faced a hiccup with its Pixel 8 smartphone lacking the Gemini Nano AI feature, and Progressive received an upgrade from Morgan Stanley.
March 13, 2024 | 1:25 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alphabet's setback with the Pixel 8 smartphone missing the Gemini Nano AI feature may temper investor enthusiasm.
The absence of the anticipated Gemini Nano AI feature in the Pixel 8 smartphone could disappoint investors and users, potentially leading to a negative short-term impact on Alphabet's stock price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
D.R. Horton's attractive valuation at 11 times earnings and anticipated Q2 financial results could interest investors.
D.R. Horton's attractive valuation and the upcoming release of its Q2 financial results may generate investor interest, potentially leading to a positive short-term impact on the stock price.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Pfizer's Phase 3 study of Adcetris shows significant improvement in survival for DLBCL, potentially boosting investor confidence.
The positive results from the Phase 3 study are likely to enhance Pfizer's reputation in oncology, potentially leading to increased investor confidence and a positive impact on the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Progressive's solid earnings and growth prospects, highlighted by a Morgan Stanley upgrade, suggest a positive outlook.
The upgrade by Morgan Stanley from Equal-Weight to Overweight and the increase in price target reflect a strong vote of confidence in Progressive's financial health and growth prospects, likely contributing to a positive short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85